OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Abiomed INC ABIOMED ORD SHS/  US0036541003  /

London Domestic
2022-12-21  6:56:16 PM Chg. - Volume Bid6:00:09 AM Ask6:00:09 AM Market Capitalization Dividend Y. P/E Ratio
380.7907USD - 110
Turnover: 3,807.3628		 -Bid Size: - -Ask Size: - 17.18 bill.USD - 127.01

Assets

 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD		 2022
US GAAP
in mill. USD
Property and Equipment
  117.1670   145.0050   164.9310   197.1290   202.4900
Intangible Assets
  -   -   -   42.1500   39.5180
Long-Term Investments
  37.5020   21.7180   207.7950   264.0850   220.0890
Fixed Assets
  292.1040   377.1490   580.5990   706.3940   696.9200
Inventories
  50.2040   80.9420   90.0880   81.0590   93.9810
Accounts Receivable
  70.0100   90.8090   84.6500   97.1790   90.6080
Cash and Cash Equivalents
  42.9750   121.0210   192.3410   232.7100   132.8180
Current Assets
  494.2710   677.1970   635.8630   787.9650   976.4730
Total Assets
  786.3750   1,054.3460   1,216.4620   1,494.3590   1,673.3930

 

Liabilities

 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD		 2022
US GAAP
in mill. USD
Accounts Payable
  23.5650   32.1850   32.7740   34.8420   35.3460
Long-term debt
  0.0000   0.0000   0.0000   -   -
Liabilities to Banks
  -   -   -   -   -
Provisions
  .9000   .8000   .8000   .8000   .8000
Liabilities
  96.8510   117.4560   150.9960   164.6840   170.0670
Share Capital
  .4440   .4510   .4510   .4530   .4550
Total Equity
  689.5240   936.8900   1,065.4660   1,329.6750   1,503.3260
Minority Interests
  -   -   -   -   -
Total liabilities equity
  786.3750   1,054.3460   1,216.4620   1,494.3590   1,673.3930

 

Income Statement

 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD		 2022
US GAAP
in mill. USD
Revenues
  593.7490   769.4320   840.8830   847.5220   1,031.7530
Depreciation (total)
  11.0050   14.1210   20.4300   24.0970   28.0890
Operating Result
  157.1370   224.8120   249.2190   229.5570   140.7200
Interest Income
  3.6880   8.1660   12.1670   6.7170   49.8400
Income Before Taxes
  160.4370   263.3600   256.8250   288.2200   190.5600
Income Taxes
  48.2670   4.3440   53.8160   62.6950   54.0550
Minority Interests Profit
  -   -   -   -   -
Net Income
  112.1700   259.0160   203.0090   225.5250   136.5050

 

Per Share

 2018
US GAAP
in USD		 2019
US GAAP
in USD		 2020
US GAAP
in USD		 2021
US GAAP
in USD		 2022
US GAAP
in USD
Earnings per Share
  2.5400   5.7700   4.4900   5.0000   3.0000
Dividend per Share
  -   -   -   -   -

 

Cash Flow

 2018
US GAAP
in mill. USD		 2019
US GAAP
in mill. USD		 2020
US GAAP
in mill. USD		 2021
US GAAP
in mill. USD		 2022
US GAAP
in mill. USD
Cash Flow from Operating Activities
  192.5460   252.1970   314.9200   274.5780   285.3900
Cash Flow from Investing Activities
  -180.7620   -116.4550   -125.4550   -223.3440   -380.9900
Cash Flow from Financing
  -9.1370   -55.7750   -117.7150   -8.0670   -2.2020
Decrease / Increase in Cash
  3.9350   78.0460   71.3200   40.3690   -99.8920
Employees
  1,143   1,371   1,536   1,725   2,003